JINSONG LIU, M.D.
Medical Practice at Holcombe Blvd, Houston, TX
License number
Texas K9838
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Professional information
Use Of Tumor Susceptibilty Gene 101 (Tsg 101) As A Prognostic And Diagnostic Marker
US Patent:
7897340, Mar 1, 2011
Filed:
Feb 13, 2007
Appl. No.:
11/706109
Inventors:
Xiaodong Cheng - League City TX, US
Fang Mel - League City TX, US
Travis Young - Galveston TX, US
Jinsong Liu - Houston TX, US
Fang Mel - League City TX, US
Travis Young - Galveston TX, US
Jinsong Liu - Houston TX, US
Assignee:
The Board of Regents of the University of Texas System - Austin TX
International Classification:
C12Q 1/68, G01N 33/53
US Classification:
435 6, 435 71
Abstract:
The present invention discloses the link between oncogenic Ras and TSG101 and the negative effect of TSG101 on the expression of p21 in ovarian cancer. The present also discloses the use of TSG101 as a prognostic, diagnostic marker and a potential therapeutic target in cancer, especially ovarian cancer.
Jinsong Liu, Houston TX
Specialties:
Pathologist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
Shanghai Medical University - Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology)
Dr. Jinsong Liu, Houston TX - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
1515 Holcombe Blvd, Houston 77030
(713) 792-6161 (Phone)
Houston Office
1515 Holcombe Blvd STE 10, Houston 77030
(877) 632-6789 (Phone)
(713) 792-6161 (Phone)
Houston Office
1515 Holcombe Blvd STE 10, Houston 77030
(877) 632-6789 (Phone)
Certifications:
Anatomic Pathology, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1515 Holcombe Blvd, Houston 77030
Houston Office
1515 Holcombe Blvd STE 10, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Houston Office
1515 Holcombe Blvd STE 10, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Education:
Medical School
Shnaghai Med Univ
New York Clin Med Ctr
Shnaghai Med Univ
New York Clin Med Ctr
Oncogenic Ras-Specific Cytotoxic Compound And Methods Of Use Thereof
US Patent:
2009028, Nov 19, 2009
Filed:
Nov 22, 2006
Appl. No.:
12/094739
Inventors:
Bingliang Fang - Pearland TX, US
Jinsong Liu - Houston TX, US
Wei Guo - Houston TX, US
Shuhong Wu - Houston TX, US
Jinsong Liu - Houston TX, US
Wei Guo - Houston TX, US
Shuhong Wu - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
A61K 31/405, C12N 5/06
US Classification:
514415, 435375
Abstract:
Embodiments of the present invention provide for methods and compositions comprising an Oncorasin, such as 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1) and/or its analogs or derivatives.
Uses Of Circadian Gene Mper2
US Patent:
2004016, Aug 19, 2004
Filed:
Jul 25, 2003
Appl. No.:
10/627207
Inventors:
Cheng-Chi Lee - Houston TX, US
Loning Fu - Houston TX, US
Peng Huang - Bellaire TX, US
Jinsong Liu - Houston TX, US
Loning Fu - Houston TX, US
Peng Huang - Bellaire TX, US
Jinsong Liu - Houston TX, US
International Classification:
A61K048/00, C12N015/86
US Classification:
424/093200, 435/456000
Abstract:
Data presented herein provide a molecular mechanism for circadian gene mPer2 in DNA damage response and tumor suppression in vivo. Mice deficient in mPer2 gene display neoplastic phenotypes. These mice are deficient in p53-mediated apoptosis in thymocytes and have increased tumor occurrences after -radiation. Core circadian genes are induced by -radiation in wild-type mice but not in mPer2 mutant mice. Temporal expression of genes involved in cell cycle regulation and tumor suppression, such as c-Myc, Cyclin D1, Cyclin A, Mdm-2 and Gadd45 is dependent on mPER2 in vivo.